COYA

2.9501.01%
FG

Fred Grossman

President & Chief Medical Officer

Dr. Fred Grossman, D.O., FAPA, serves as President and Chief Medical Officer of Coya Therapeutics, Inc. since July 17, 2023. He serves as Director at Reunion Neuroscience Inc. since April 03, 2023. He served as Chief Medical Officer of Empyrean Neuroscience, Inc. He served as Chief Medical Officer of Mesoblast Limited since August 19, 2019 until January 30, 2022 and served as its Advisor since February 2022 until January 31, 2023. He joined Mesoblast Limited in August 2019. Dr. Grossman served as Chief Medical Officer at NeuroRx Inc since 2018 until August 2019. He was President of Glenmark Pharmaceuticals Ltd., until August 2018. Dr. Grossman was Chief Medical Officer at Glenmark Pharmaceuticals Ltd. until June 18, 2018. He served as Head of Global Clinical Development & Medical Affairs at Sunovion Pharmaceuticals Inc. from April, 2015 until November, 2015 and as its Senior Vice President of Clinical Development and Medical Affairs from October, 2011 until April, 2015. He joined Glenmark in November 2015. He has leadership experience, having held senior positions at Eli Lilly, Sunovian Pharmaceuticals, Bristol-Myers Squibb (BMS) and Johnson & Johnson (J&J). During his career, he has managed global clinical development, pharmacovigilance, medical affairs and clinical operations for innovative product development, as well as United States Food and Drug Administration (FDA) approvals and post-market support for numerous blockbuster, specialty and generic products. Dr. Grossman has led and built teams in the United States, Europe and Japan with responsibility for global medical affairs, global clinical development, health economics & outcomes research (HEOR) and global drug safety. At J&J and Eli Lilly, Dr. Grossman was responsible for multiple New Drug Applications (NDAs) to the FDA. At BMS, he was Global Head of the Medical Affairs organization, with focus on immunology and cardiovascular diseases. Dr. Grossman holds a Doctor of Osteopathic Medicine Degree from Southeastern University of the Health Sciences in the United States and completed Psychiatry Training at the University of Pennsylvania and the National Institute of Health.

Positions